Nichols, T. C., Levy, H., Merricks, E. P., Raymer, R. A., & Lee, M. L. (2020). Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa. PLoS ONE, 15(10), 1. https://doi.org/10.1371/journal.pone.0240896
Chicago Style (17th ed.) CitationNichols, Timothy C., Howard Levy, Elizabeth P. Merricks, Robin A. Raymer, and Martin L. Lee. "Preclinical Evaluation of a Next-generation, Subcutaneously Administered, Coagulation Factor IX Variant, Dalcinonacog Alfa." PLoS ONE 15, no. 10 (2020): 1. https://doi.org/10.1371/journal.pone.0240896.
MLA (9th ed.) CitationNichols, Timothy C., et al. "Preclinical Evaluation of a Next-generation, Subcutaneously Administered, Coagulation Factor IX Variant, Dalcinonacog Alfa." PLoS ONE, vol. 15, no. 10, 2020, p. 1, https://doi.org/10.1371/journal.pone.0240896.